Bordetella bronchiseptica is a bacterium that affects a wide range of animals, causing various respiratory diseases. While it is closely related to Bordetella pertussis, which causes whooping cough in humans, B. bronchiseptica primarily impacts animals. This article explores the bacterium's effects on different animal species, its pathogenesis, and the challenges it poses in veterinary medicine.
Impact on Different Animal Species
Bordetella bronchiseptica is a significant pathogen in
veterinary medicine, affecting dogs, pigs, rabbits, and occasionally cats, horses, and seals. In dogs, it is a primary cause of kennel cough, a contagious respiratory disease characterized by a persistent cough. The bacterium can also infect pigs, where it acts synergistically with Pasteurella multocida to cause atrophic rhinitis, a condition that leads to arrested growth and nasal deformities.
In rabbits, B. bronchiseptica is often found in the nasal tract, co-infecting with Pasteurella multocida. While it is assumed to cause a nearly asymptomatic infection known as snuffles, the primary causative agent is Pasteurella multocida. In cats, the bacterium can cause tracheobronchitis, conjunctivitis, and rhinitis, although these conditions can also be caused by other pathogens such as herpesvirus and calicivirus.
Pathogenesis and Resistance
Bordetella bronchiseptica infects the respiratory tracts of smaller mammals and is generally resistant to macrolide antibiotics and cephalosporins. Unlike B. pertussis, it does not express the pertussis toxin, but it has the genetic capability to do so, indicating a close evolutionary relationship between the two species.
The bacterium's resistance to common antibiotics poses a challenge in veterinary medicine. However, some human cases have been successfully treated with trimethoprim/sulfamethoxazole and fluoroquinolones. In animals, the infection is often self-limiting, but severe cases may require veterinary intervention.
Veterinary Challenges and Solutions
The persistence of Bordetella bronchiseptica in the environment and its ability to infect multiple species make it a challenging pathogen to control. In veterinary settings, preventive measures such as vaccination and proper hygiene are crucial in managing outbreaks. For instance, an intranasal vaccine exists for cats, providing some level of protection against the bacterium.
In late 2022, a surge in canine infections involving B. bronchiseptica was observed, partly due to increased human travel and changes in pet ownership behaviors following the COVID-19 pandemic. These factors led to overcrowded animal shelters and more dogs being placed in kennels, facilitating the spread of the bacterium. Addressing these challenges requires a coordinated effort in veterinary care, public health measures, and responsible pet ownership.
